` Comparison: 2610 vs KNRS - Alpha Spread

2610
vs
KNRS

Over the past 12 months, China Airlines Ltd has outperformed KNRS, delivering a return of -11% compared to the KNRS's 0% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
2610
KNRS
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

China Airlines Ltd Intrinsic Value
HIDDEN
Show
KNRS Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
China Airlines Ltd
TWSE:2610
21.1 TWD
Kinarus Therapeutics Holding AG
SIX:KNRS
15 CHF
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
2610, KNRS

2610
KNRS
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
China Airlines Ltd
Revenue
Kinarus Therapeutics Holding AG
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
2610, KNRS

2610
KNRS
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
China Airlines Ltd
TWSE:2610
Kinarus Therapeutics Holding AG
SIX:KNRS
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

China Airlines Ltd
17.7%
KNRS
0%

Operating Margin

China Airlines Ltd
9.9%
KNRS
0%

Net Margin

China Airlines Ltd
7.2%
KNRS
0%

FCF Margin

China Airlines Ltd
-12.3%
KNRS
0%

ROE

China Airlines Ltd
17%
KNRS
-237.1%

ROA

China Airlines Ltd
4.6%
KNRS
-219.8%

ROIC

China Airlines Ltd
5.9%
KNRS
-247.6%

ROCE

China Airlines Ltd
8.6%
KNRS
-237%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
2610, KNRS

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
2610, KNRS

Performance Gap Between 2610 and KNRS
HIDDEN
Show

Performance By Year
2610, KNRS

Loading
2610
KNRS
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 2610 to other stocks
DAL
Delta Air Lines Inc
More expensive
vs China Airlines Ltd
UAL
United Airlines Holdings...
More expensive
vs China Airlines Ltd
IAG
International Consolidat...
Cheaper
vs China Airlines Ltd
LUV
Southwest Airlines Co
More expensive
vs China Airlines Ltd
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett